ArticleDiscover mental health2026
A multidimensional astrocytic framework links serum biomarkers to depression subtypes cognition and sleep EEG.
Article in Discover mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sleep in Bipolar Disorder: A Systematic Review and Meta-Analysis of Case-Control Drug-Free Patients.Brain sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate changed levels of serum astrocytic biomarkers, including glial cell line-derived neurotrophic factor (GDNF), aldehyde dehydrogenase (ALDH) and connexin-26, and the correlations with depression subtypes, cognitive dysfunction and electroencephalogram measures in patients with depression disorder (DD).
methodsSeventy-three patients and 46 healthy subjects (HC) were enrolled. Questionnaires, Nine Box Maze Test (NBMT) were used to assess sleep and neuropsychology. Serum biomarkers were evaluated with enzyme-linked immunosorbent assay. Partial subjects (45 DD and 10 HC) completed polysomnography.
resultsCompared to the HC, the patients had lower levels of GDNF, ALDH and connexin-26, and increased errors in NBMT tasks, including spatial/object working memory (SWM/OWM) and spatial/object reference memory (SRM/ORM). The connexin-26 concentration was higher in recurrent depression relative to dysthymia and bipolar depression; and GDNF concentrations was higher in the first episode depression compared to the recurrent depression and bipolar depression, with the lowest concentration in dysthymia. Partial correlation analysis for patients showed that the GDNF positively associated with N3% and power of delta wave; ALDH positively associated with MMSE score and OWM error; and connexin-26 negatively correlated with ORM and SRM errors.
conclusionDepressive patients had decreased serum levels of GDNF, ALDH and CX26, with subtype-specific difference in GDNF and CX26, which were associated with impaired cognition and slow wave power of electroencephalogram.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.